Kytopen
PrivateLast Round
Series B
Apr 7, 2026
Total Funding Raised
$44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kytopen operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in April 2026.
Kytopen is a biotechnology company that provides a cell engineering platform for producing healthy and functional cells quickly and efficiently.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kytopen Comparables
Compare Kytopen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trince | 86% | |
| Portal Biotechnologies | 85% | |
| Portal Biotechnologies | 84% |
For institutional investors. Book with your work email.
Kytopen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 7, 2026 | ||||
| Early Funding | Feb 6, 2025 | ||||
| Grant | Aug 13, 2024 | ||||
| Convertible Debt | Feb 14, 2024 | ||||
| Series A | Sep 28, 2021 | ||||
Grant | Jun 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kytopen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Series B, Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Engine | Series A, Series B, Pre Seed, Seed |
| Engine Ventures | Series A, Seed, Series B |
| MassVentures | Series A, Series B, Grant |
| Northpond Ventures | Series B, Series A |
| Alexandria Venture Investments | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 51% MoM.
- Apr 7, 2026
Raised Series B round.
For institutional investors. Book with your work email.
Kytopen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kytopen's valuation, stock price, and market status.
Is Kytopen a public or private company?
Kytopen is a private company.
What is the current stock price of Kytopen?
Kytopen is a private company, so its shares have no public market price. Caplight tracks Kytopen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kytopen worth (valuation)?
Valuation information for Kytopen is not publicly available.
Can I buy Kytopen stock?
Kytopen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kytopen's last funding round?
Kytopen's most recent funding round was Series B on April 7, 2026.
Who are the main investors in Kytopen?
Key investors in Kytopen include Horizons Ventures, The Engine, MassVentures, Northpond Ventures, Telegraph Hill Partners.
Will Kytopen IPO soon?
No public IPO plans have been announced for Kytopen.
How can I track Kytopen secondary market activity?
Caplight tracks bids, offers, and trades in Kytopen's shares on secondary markets.